A new UK research centre specialising in the development of new tropical medicines has been given the go-ahead with £18 …
Doctors and health campaigners have expressed their deep disappointment over the government's failure to introduce a complete smoking ban in …
Members of the public will now be able to report adverse events in medicines direct to the UK watchdog through …
A marketing alliance between Merck and Schering-Plough has given the troubled companies some positive news to report.Global sales of the …
Pfizer, the pharma industry's powerhouse, has suffered a 52% slump in profits in the third quarter, undermining investor confidence in …
A survey of marketers across industry sectors has underlined the importance of their role but shows many have to battle …
Tony Blair and Labour were re-elected in May this year for an historic third-term, with the electorate telling pollsters they …
A promising antibody developed by UK-based Oxford BioMedica is poised to enter clinical trials to treat lung cancer.The 5T4 antibody-targeted …
UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …
Since pharma'ps big wave of innovation during the early 1990s, peaking in 1996 when 131 new drug applications were filed …
Vaccine companies are to compete with each other to produce a vaccine against a potential pandemic flu – although no-one …
Competition in one of the industry's fastest growing markets is intensifying with new approvals for two TNF-blocker drugs.Schering-Plough and Centocor's …
Healthcare agency Resolute Communications has been named consultancy of the year at the PRWeek awards, believed to be the first …
The world's first-ever contraceptive pill to offer women complete freedom from menstruation could be launched by next year.Wyeth's Lybrel is …
Early results from trials suggest adding Tarceva to Avastin has no extra benefit in the treatment of kidney cancer.Researchers at …
The government sees choice as a major driver for promoting quality, responsiveness, efficiency and equity in public services. Choice in …
Merck is to develop a new monoclonal antibody which has shown promise in treating prostate cancer.The US company has signed …
Exubera, the first ever inhaled insulin product is set for approval in Europe following a key regulatory recommendation.The positive opinion …
The new onus on outsourcing has seen CROs reap the benefits of an industry striving to cut resource investment while …
Pharmaceutical companies are being urged to step up vaccine production as the strain of bird flu that killed 59 people …